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geographic variation in receipt of therapy, despite adjust-
ment for clinical characteristics, may be explained not only
by psychologist supply but also by parent, child, or pediatri-
cian preferences for or comfort with nonpharmacologic
care.
We acknowledge limitations common to analyses of
claims data, including no information on services that were
not billed to commercial insurance and a limited ability to
determine severity of illness or clinical appropriateness for
therapy. We cannot comment on therapy receipt in those
smaller and more rural counties that we excluded. Nonethe-
less, our study is the first, to our knowledge, to document
the substantial variation in receipt of therapy services
among US children treated with ADHD medications and is
directly relevant to the ongoing public discourse about how
this common condition should be treated.
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COMMENT&RESPONSE
Undertreated andUntreated Pain
Should Be Considered anAdverse Event
of Neonatal Circumcision
To the Editor We read with great interest the article by
El Bcheraoui et al1 recently published in JAMA Pediatrics.
We believe that the rates of adverse events of male circum-
cision may have been underestimated. As a matter of fact,
the authors did not mention intraoperative and postopera-
tive pain as an adverse effect, especially in neonates. None-
theless, authors in other studies consider undertreating
or untreating procedural pain to be an actual adverse
event.2
An adverse event is defined as an injury related to medi-
cal management, including failure to diagnose and treat. Un-
treatedmale circumcision pain has been shown to determine
long-lastingnegative effects on future infant behavior.3 In ad-
dition, current guidelines recommend analgesia for neonatal
male circumcision.4 Analgesia is now considered an integral
part of routine care whatever the invasive procedure is, par-
ticularly in neonates and children.
Unfortunately, it has been evidenced that analgesia for
procedural pain in children is not routine in neonatal male
circumcision.5 Relief from pain is a human right that should
never be violated, even if a neonate's parents give consent.
We hope that future studies similar to that by El Bcheraoui
et al1 will include intraoperative and postoperative pain
when estimating the risk of adverse effects for neonatal
male circumcision.
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InReplyWethankBisognietal for their comments recentlypub-
lished in JAMAPediatrics about intraoperative andpostopera-
tive pain as an adverse event (AE) to male circumcision (MC).
Use of appropriate analgesia for pain management is a good
practice that should be the standard of care during and after
any surgical procedure because it can substantially control
pain.1 Inaprospective studyof583neonatal circumcisionsper-
formed between December 1, 2005, and December 1, 2008,
whenappropriateanalgesiawasapplied,93.5%ofneonatescir-
cumcised in the firstweekof life showedno indication of pain
onanobjective standardizedneonatal pain rating systemused
by the authors.2
The recently published article,3 which found a low inci-
dence of AEs (less than 0.5%) associated with MC in USmedi-
cal settings during 2001 to 2010, is based on data fromahealth
care reimbursement claims database. This database captures
onlydiagnosesandproceduresbilledtothirdparties.Theanaly-
sis studied the association between 41 AEs, not including pain
andMC.Asearchof thesamehealthcare reimbursementclaims
database for the International Classification of Diseases, Ninth
Revisioncodes338.18(otheracutepostoperativepain)and338.19
(other acute pain) detected 1 patientwith pain associatedwith
the MC procedure among 1 400 920 circumcised males. Tak-
ing intoconsiderationthepossibility thatpainmaybeanunder-
reported AE in the health care reimbursement claims’ data-
base used for this analysis, a more thorough analysis of the
association of pain and MC would require additional data
sources, including informationrelatedtouseofandtypeofpain
controlmethods.Aspreviouslyrecommended,3 futureresearch-
ers studying the association between AEs andMC should con-
siderusingadditionaldata sources toascertainAEs that arenot
captured in data from reimbursement claims.
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NebulizedHypertonic Saline for Bronchiolitis
To theEditorWereadwith interest thestudybyWuetal1 recently
published inJAMAPediatrics, examiningtheeffectofnebulized
hypertonicsalinevsnormalsalineadministrationin infantswith
bronchiolitis.Wecommend the authors forundertaking a large
randomizedclinical trial tocomplementexistingevidenceof the
decreasinglengthofstaywithhypertonicsalineuse.2-5However,
wehaveconcernsregardingthestudyanalysisandinterpretation
andbelievecautious interpretationof the findings iswarranted.
While3447patientswerediagnosedwithbronchiolitisdur-
ing the studyperiod, only 1254patientswereassessed for eligi-
bility.Therewasnoexplanationwhya largenumberofpatients
was not assessed; thismay have affected the population stud-
ied,potentially skewing thedata towardamoremild tomoder-
ate spectrumof illness (indicatedby the reportedpretreatment
RespiratoryDistressAssessment Instrument scores). The large
numberofchildrendischargedfromtheemergencydepartment
mayalso reflectmilderdisease.Unfortunately, the lackofmini-
mumormaximum severity criteria for study entry and lack of
stratificationofseverityconfoundstheefficacyofhypertonicsa-
line use in a diseasewith a known spectrumof severity.
Wequestion theclinical significanceof length-of-staydata
whenmeasured indaysbecausethis isabluntmeasure forshort
admissions.Giventhatthestudywasunderpoweredforthisout-
come, we suggest using hours instead of days, with a survival
analysis to investigatetimefromemergencydepartmentpresen-
tationtodischarge.Theadvantagewouldbetheuseofdatafrom
all randomized patients in the analysis, not only admitted pa-
tients,presentinga richerdata setwithmoreclinical relevance.
Additionally, as the length-of-staydataarenotnormallydistrib-
uted, itwouldhavebeenmore informative to report themedian
andinterquartilerangeratherthanmeanandstandarddeviation.
Wearealsoconcernedthat theRespiratoryDistressAssessment
Instrumentscoreduringadmissionwasassessedatdailypoints
onlyandwasnotreflectiveofpretreatmentseverityorposttreat-
mentoutcome. Intherelevantanalyses, theauthorsonlyappear
toconsiderthepre-andpostmeasurementsofthefirsttreatment.
To conclude,while hypertonic saline use in childrenwith
bronchiolitis in the emergency department appears to de-
crease admission to the hospital, it remains unclear whether
this applies to all cases of bronchiolitis, irrespective of sever-
ity, given the lack of stratification. As β-agonist and nebu-
lized saline administration are not universal for bronchiolitis
in all settings, this would be important information to allow
generalizability of findings.
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